• Profile
Close

Muscle relaxant use among hemodialysis patients: Prevalence, clinical indications, and adverse outcomes

American Journal of Kidney Diseases Jan 16, 2019

Mina D, et al. - A total of 140,899 Medicare-covered adults who had hemodialysis in 2011, were assessed by the investigators to estimate the prevalence, clinical indications, and adverse consequences of muscle relaxant use in hemodialysis patients in this observational cohort study. They categorized time to first emergency department visit or hospitalization for altered mental status, fall, or fracture as primary outcomes; death and composites of death with each of the primary outcomes were secondary outcomes. They observed that muscle relaxant use was linked to a greater risk for altered mental state and fall vs no use. They observed that 11%, 6%, 3%, and 13% of patients had an incident of altered mental status, fall, fracture, and death, respectively. The lower prevalence of death with muscle relaxants could result from the effect of residual confounding.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay